Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study.

Name: Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study.
Author: Shivaprakash, G

Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study. — المؤلف: Shivaprakash, G — Indian journal of pharmacology 20181002

المؤلف: Shivaprakash, G
النشر: Indian journal of pharmacology 20181002
الوصف: 451-457 p.
الموضوعات: Antiemetics؛ Antineoplastic Combined Chemotherapy Protocols؛ Aprepitant؛ Benzodiazepines؛ Breast Neoplasms؛ Cyclophosphamide؛ Doxorubicin؛ Female